Literature DB >> 22504395

Progress in cell membrane chromatography.

L C He1, S C Wang, G D Yang, Y M Zhang, C H Wang, B X Yuan, X F Hou.   

Abstract

Cell membrane chromatography (CMC) was first established by He et al. in 1996. A bioaffinity chromatography technique, CMC has since proven to be an important method for studying drug-receptor interactions and screening active compounds from medicinal herbs. This paper briefly reviews the characteristics of the cell membrane stationary phase (CMSP), the CMC analytical system, and its applications.

Year:  2007        PMID： 22504395

Source DB:  PubMed          Journal:  Drug Discov Ther        ISSN： 1881-7831


  4 in total

Review 1.  Comparison of analytical techniques for the identification of bioactive compounds from natural products.

Authors:  Łukasz Cieśla; Ruin Moaddel
Journal:  Nat Prod Rep       Date:  2016-07-01       Impact factor: 13.423

2.  I n situ synthesis and unidirectional insertion of membrane proteins in liposome-immobilized silica stationary phase for rapid preparation of microaffinity chromatography.

Authors:  Yanqiu Gu; Rong Wang; Panpan Chen; Shengnan Li; Xinyi Chai; Chun Chen; Yue Liu; Yan Cao; Diya Lv; Zhanying Hong; Zhenyu Zhu; Yifeng Chai; Yongfang Yuan; Xiaofei Chen
Journal:  Acta Pharm Sin B       Date:  2022-04-22       Impact factor: 14.903

3.  Comparative normal/failing rat myocardium cell membrane chromatographic analysis system for screening specific components that counteract doxorubicin-induced heart failure from Acontium carmichaeli.

Authors:  Xiaofei Chen; Yan Cao; Hai Zhang; Zhenyu Zhu; Min Liu; Haibin Liu; Xuan Ding; Zhanying Hong; Wuhong Li; Diya Lv; Lirong Wang; Xianyi Zhuo; Junping Zhang; Xiang-Qun Xie; Yifeng Chai
Journal:  Anal Chem       Date:  2014-04-30       Impact factor: 6.986

4.  Dexamethasone inhibits SARS-CoV-2 spike pseudotyped virus viropexis by binding to ACE2.

Authors:  Yongjing Zhang; Shiling Hu; Jue Wang; Zhuoyin Xue; Cheng Wang; Nan Wang
Journal:  Virology       Date:  2020-12-16       Impact factor: 3.513
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.